Navigation Links
House Tri-Committee Bill Would Hurt Patients and Kill Jobs
Date:7/31/2009

WASHINGTON, July 31 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement after the Energy and Commerce Committee mark-up of the House Tri-Committee bill:

"PhRMA remains committed to working with the Administration and Congress to help enact comprehensive health care reform this year. Our policy agreement with the White House and the Senate Finance Committee, which provides $80 billion in meaningful cost-savings over 10 years, clearly demonstrates that commitment. We share the same goal of helping ensure that all Americans have access to affordable, high-quality health care coverage and services.

"We applaud members on the House Energy & Commerce Committee for passing a bipartisan biosimilars amendment that strikes an appropriate balance between the desire for enhanced competition and preserving incentives for innovation. Such incentives are vital for ensuring continued development of biologics that patients with complex diseases rely on today and will help to provide cures in the future. Recently, the Senate HELP Committee also agreed overwhelmingly to support this important provision.

"Unfortunately, the totality of the efforts in the U.S. House of Representatives, while well-intentioned, represents a step in the wrong direction in the health care reform debate.

"PhRMA opposes the House Tri-Committee bill because it undercuts the main goal of health care reform which is to help all Americans access needed healthcare coverage and services. The bill would effectively act as a tax increase by raising premiums for seniors in the popular Medicare prescription drug program, severely restrict patient access and choice and hurt an innovative sector that currently employs hundreds of thousands of workers. The result could mean significant job losses in the middle of a recession. In addition, the legislation allows broad override of protections for Medicare and Medicaid beneficiaries by unelected officials, with no chance for review.

"Under the House bill, we're concerned that the federal government will wind up rationing health care and dictating what medicines doctors can prescribe to their patients. This may well prevent patients from gaining access to the critically important medicines they need to fight diseases such as cancer, diabetes and heart disease.

"What's more, even the Congressional Budget Office has said that government negotiation of Medicare Part D prices would save little, if any, money.

"While we will continue to work toward supporting comprehensive health care reform, we will vigorously oppose legislation that hurts patients and the American economy."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

    PhRMA Internet Address:http://www.phrma.org
    For information on stories of hope and survival, visit:
   http://sharingmiracles.com/
    For information on how innovative medicines save lives, visit:
   http://www.innovation.org
    For information on the Partnership for Prescription Assistance, visit:
   http://www.pparx.org
    For information on the danger of imported drugs, visit:
   http://www.buysafedrugs.info
    For more information on public health emergencies, visit:
   http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Webcast Alert: Kaiser Permanente Residency Program Open House
2. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
3. Retailers Welcome Senate Passage of Mental Health Parity Bill, Urge House to Adopt Senate Version at Subcommittee Markup
4. CRC Health Group Announces Acquisition of Durhams Structure House, Weight Loss Facility
5. Senate, House Announce Agreement to Renew, Improve Childrens Health Insurance Program Now
6. Statement on House/Senate Agreement on SCHIP Legislation
7. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
8. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
9. House of Representatives Passes Stop AIDS in Prison Act of 2007
10. Green Seal Ramps Up Environmental Standard for Household Cleaners
11. Pelosi Statement on House Vote to Extend Family and Medical Leave for Military Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: